4.7 Article

Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD

期刊

BRAIN BEHAVIOR AND IMMUNITY
卷 80, 期 -, 页码 889-899

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2019.05.042

关键词

Post-traumatic stress disorder; Stress; Microglia; Dendritic spines; Complement cascade; Hippocampus; Medial prefrontal cortex; Male mice

向作者/读者索取更多资源

Few animal models exist that successfully reproduce several core associative and non-associative behaviours relevant to post-traumatic stress disorder (PTSD), such as long-lasting fear reactions, hyperarousal, and subtle attentional and cognitive dysfunction. As such, these models may lack the face validity required to adequately model pathophysiological features of PTSD such as CNS grey matter loss and neuroinflammation. Here we aimed to investigate in a mouse model of PTSD whether contextual fear conditioning associated with a relatively high intensity footshock exposure induces loss of neuronal dendritic spines in various corticolimbic brain regions, as their regression may help explain grey matter reductions in PTSD patients. Further, we aimed to observe whether these changes were accompanied by alterations in microglial cell number and morphology, and increased expression of complement factors implicated in the mediation of microglial cell-mediated engulfment of dendritic spines. Adult male C57B16J mice were exposed to a single electric footshock and subsequently underwent phenotyping of various PTSD-relevant behaviours in the short (day 2-4) and longer-term (day 29-31). 32 days post-exposure the brains of these animals were subjected to Golgi staining of dendritic spines, microglial cell Iba1 immunohistochemistry and immunofluorescent staining of the complement factors Clq and C4. Shock exposure promoted a lasting contextual fear response, decreased locomotor activity, exaggerated acoustic startle responses indicative of hyperarousal, and a short-term facilitation of sensorimotor gating function. The shock triggered loss of dendritic spines on pyramidal neurons was accompanied by increased microglial cell number and complexity in the medial prefrontal cortex and dorsal hippocampus, but not in the amygdala. Shock also increased expression of Clq in the pyramidal layer of the CAI region of the hippocampus but not in other brain regions. The present study further elaborates on the face and construct validity of a mouse model of PTSD and provides a good foundation to explore potential molecular interactions between microglia and dendritic spines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

A novel estimation method for the counting of dendritic spines

Mustafa S. Kassem, Bernard W. Balleine

Summary: This study investigates the dendrites of neuronal cells and the synaptic spines associated with them, highlighting the possibility of inaccurate counting due to the use of certain imaging technologies. By developing a mathematical model, the researchers propose a more unbiased estimation method for quantifying the number of spines on dendrites. Using this new method, the study reveals that previous studies may have been biased in their morphological analysis. The researchers have created a user-friendly website where researchers can input data to obtain more accurate estimates of spine counts. This method improves the validity of spine measurement and allows for a reevaluation of previously published work.

JOURNAL OF NEUROSCIENCE METHODS (2022)

Article Substance Abuse

Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition

Llewellyn Mills, Nicholas Lintzeris, Michael O'Malley, Jonathon C. Arnold, Iain S. McGregor

Summary: This study examined the prevalence and correlates of cannabis use disorder (CUD) in people who use cannabis for medical reasons. The results showed that the prevalence of CUD in medical cannabis users is comparable to 'recreational' users, with many similar correlates. The strongest correlates with CUD were the inhaled route of administration, frequency of cannabis use, proportion of cannabis for medical reasons, frequency of tobacco use, age, and main clinical indication being mental health issues.

DRUG AND ALCOHOL REVIEW (2022)

Article Pharmacology & Pharmacy

Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro

Somayeh Mirlohi, Chris Bladen, Marina J. Santiago, Jonathon C. Arnold, Iain McGregor, Mark Connor

Summary: This study investigates the modulation of T-type calcium channels by low abundance phytocannabinoids. It found that these phytocannabinoids can regulate neuronal excitability and neurotransmitter release by modulating T-type calcium channels, and that these channels may be an important site of action for phytocannabinoids.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters

Maia G. Etchart, Lyndsey L. Anderson, Adam Ametovski, Peter M. Jones, Anthony M. George, Samuel D. Banister, Jonathon C. Arnold

Summary: This study examined the effects of cannabichromene (CBC) and cannabichromenic acid (CBCA) on ABCB1 and ABCG2 transporters. The results showed that CBCA is a substrate of ABCB1, while CBC is neither a substrate nor an inhibitor of ABCB1 or ABCG2. These findings are important for the therapeutic development of these cannabis constituents.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Letter Pharmacology & Pharmacy

A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine A Case Report

Lyndsey L. Anderson, Jonathon C. Arnold, Iain S. McGregor, Tamara R. Nation

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2022)

Review Medicine, Research & Experimental

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

Jonathon C. Arnold, Danielle McCartney, Anastasia Suraev, Iain S. McGregor

Summary: Global interest in CBD is increasing, with clinical trial evidence supporting high doses for treating childhood epilepsies. However, the therapeutic benefits of low-dose CBD products are still being debated. This review evaluated the efficacy and safety of low oral doses of CBD and found that doses of 300 mg or higher showed evidence of reducing anxiety and anti-addiction effects, but the effects on insomnia, neurological disorders, and chronic pain were limited and inconsistent.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Biochemical Research Methods

How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials

Danielle McCartney, Richard C. Kevin, Anastasia S. Suraev, Ayshe Sahinovic, Peter T. Doohan, Miguel A. Bedoya-Perez, Ronald R. Grunstein, Camilla M. Hoyos, Iain S. McGregor

Summary: An increasing number of clinical trials are investigating the therapeutic potential of CBD, a non-intoxicating phytocannabinoid found in cannabis. These trials often use crossover experimental designs and require washout periods. The study found that CBD has a long window of detection in plasma, indicating caution should be exercised when conducting crossover studies involving CBD.

DRUG TESTING AND ANALYSIS (2023)

Article Pharmacology & Pharmacy

A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis

Zeeta Bawa, Bandana Saini, Danielle McCartney, Miguel Bedoya-Perez, Andrew J. McLachlan, Iain S. McGregor

Summary: This study examined Australian pharmacists' experience, knowledge, and attitudes towards medicinal cannabis and low-dose cannabidiol products supplied without a prescription. The results showed that pharmacists supported improved access to cannabis products but highlighted the need for better training and education in this area.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2023)

Article Pharmacology & Pharmacy

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing

Elizabeth A. A. Cairns, Melissa J. J. Benson, Miguel A. A. Bedoya-Perez, Sara L. L. Macphail, Adith Mohan, Rhys Cohen, Perminder S. S. Sachdev, Iain S. S. McGregor

Summary: There is increasing evidence that components of the Cannabis sativa plant may have therapeutic potential in treating psychiatric disorders. In Australia, medicinal cannabis products are legally available for prescription through the SAS-B. This study investigated recent prescribing practices for psychiatric indications under SAS-B and found that the majority of approvals were for anxiety disorders, sleep-wake disorders, trauma- and stressor-related disorders, and neurodevelopmental disorders, with oil products being the most prescribed.

FRONTIERS IN PHARMACOLOGY (2023)

Article Microbiology

Pathogenic Leptospira Species Are Present in Urban Rats in Sydney, Australia

Miguel A. Bedoya-Perez, Mark E. Westman, Max Loomes, Nga Yee Natalie Chung, Benjamin Knobel, Michael P. Ward

Summary: Leptospirosis is an emerging disease in Sydney, Australia, affecting both humans and dogs, and the role of rats as reservoirs of infection is still unknown. In this study, rats were collected from the City of Sydney Council area and tested for pathogenic Leptospira DNA. The results showed that 8.1% of the rats had Leptospira DNA in their kidneys. However, further testing and investigation into other wildlife reservoirs and environmental sources of leptospires are needed.

MICROORGANISMS (2023)

Article Anatomy & Morphology

HumanBrainAtlas: an in vivo MRI dataset for detailed segmentations

Mark M. Schira, Zoey J. Isherwood, Mustafa S. Kassem, Markus Barth, Thomas B. Shaw, Michelle M. Roberts, George Paxinos

Summary: We introduce the HumanBrainAtlas, which aims to create a highly detailed and open-access atlas of the living human brain by combining high-resolution in vivo MR imaging with detailed segmentations previously only available in histological preparations. We have presented and evaluated the first step of this initiative, which includes a comprehensive dataset of two healthy male volunteers reconstructed to a 0.25 mm isotropic resolution for T1w, T2w, and DWI contrasts. The dataset is virtually distortion-free, fully 3D, and compatible with existing in vivo Neuroimaging analysis tools.

BRAIN STRUCTURE & FUNCTION (2023)

Article Pharmacology & Pharmacy

Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a Scn1a+/- Mouse Model of Dravet Syndrome

Dilara Bahceci, Lyndsey L. L. Anderson, Richard C. C. Kevin, Peter T. T. Doohan, Jonathon C. C. Arnold

Summary: This study investigated the changes of endocannabinoids and related lipid signaling molecules during seizure activity. The results showed that a hyperthermia-induced seizure increased the concentration of certain monoacylglycerols in the hippocampus of Dravet syndrome mouse model, providing new clues for the development of future therapeutic approaches.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice

Cilla Zhou, Neda Assareh, Jonathon C. Arnold

Summary: CBG was found to have no effect on long-term fear memories, various conditioned fear memory processes, or stress-induced anxiety-related behavior in mice, suggesting limited potential in the treatment of PTSD and stress-related anxiety.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Pharmacology & Pharmacy

In VitroScreening of Three Commercial Cannabis-Based Products on ATP-Binding Cassette and Solute-Carrier Transporter Function

Lyndsey L. Anderson, Maia G. Etchart, Laura MacNair, M. Hunter Land, Irina A. Mosesova, Marcel O. Bonn-Miller, Jonathon C. Arnold

Summary: The legalization of medicinal cannabis has led to increased use of commercial cannabis-based products, which can potentially interact with other drugs. This study evaluated the inhibitory potential of three commercially available cannabis-based products on human transporters and found that some of these products can inhibit transporter function.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Pharmacology & Pharmacy

Evaluation of the Possible Anticonvulsant Effect of Δ9-Tetrahydrocannabinolic Acid in Murine Seizure Models

Melissa J. Benson, Lyndsey L. Anderson, Ivan K. Low, Jia Lin Luo, Richard C. Kevin, Cilla Zhou, Iain S. McGregor, Jonathon C. Arnold

Summary: Delta(9)-tetrahydrocannabinolic acid (Delta(9)-THCA) has variable anticonvulsant effects depending on the seizure model used and the presence of Delta(9)-THC. Its unstable nature poses challenges for further drug development. Future studies should focus on understanding the mechanisms by which combined Delta(9)-THCA and Delta(9)-THC alter seizure thresholds.

CANNABIS AND CANNABINOID RESEARCH (2022)

Letter Immunology

Reply to letter by Dr. Fu and Dr. Chu: Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders

Wan-Ju Cheng, Hong-Mo Shih, Kuan-Pin Su, Po-Ren Hsueh

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for COVID-19 in Brazil

Felipe Kenji Sudo, Talita P. Pinto, Fernanda G. Q. Barros-Aragao, Ivanei Bramati, Theo F. Marins, Marina Monteiro, Fernanda Meireles, Rejane Soares, Pilar Erthal, Victor Calil, Naima Assuncao, Natalia Oliveira, Joana Bondarovsky, Camila Lima, Beatriz Chagas, Alana Batista, Julia Lins, Thais L. Pinheiro, Felippe Mendonca, Andrea Silveira de Souza, Fernanda C. Rodrigues, Gabriel R. de Freitas, Pedro Kurtz, Paulo Mattos, Erika C. Rodrigues, Fernanda G. De Felice, Fernanda Tovar-Moll

Summary: Post-COVID-19 Condition (PCC) is a multisystemic syndrome that persists for months after SARS-CoV-2 infection, affecting cognitive function and neuropsychiatric features. A study on COVID-19 survivors in Brazil found that these patients experienced significant difficulties in overall cognition, memory, working memory, and inhibitory control, as well as fatigue, anxiety, and depressive symptoms. In addition, elevated levels of inflammatory markers in the blood were associated with brain microstructural damage and cognitive impairments.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Chemogenetic approaches reveal dual functions of microglia in seizures

Aastha Dheer, Dale B. Bosco, Jiaying Zheng, Lingxiao Wang, Shunyi Zhao, Koichiro Haruwaka, Min-Hee Yi, Abhijeet Barath, Dai-Shi Tian, Long-Jun Wu

Summary: Microglial activation plays a crucial role in the pathology of epilepsy, with both acute and prolonged activation affecting seizure severity and neuronal loss.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Maternal inflammation during pregnancy is associated with risk of ADHD in children at age 10

Julie B. Rosenberg, Jens Richardt Mollegaard Jepsen, Parisa Mohammadzadeh, Astrid Sevelsted, Rebecca Vinding, Mikkel E. Sorensen, David Horner, Kristina Aagaard, Birgitte Fagerlund, Susanne Brix, Nilofar Folsgaard, Ann -Marie M. Schoos, Jakob Stokholm, Bo Chawes, Christos Pantelis, Soren Dalsgaard, Birte Y. Glenthoj, Niels Bilenberg, Klaus Bonnelykke, Bjorn H. Ebdrup

Summary: Clinical data demonstrates a strong association between prenatal maternal inflammation assessed by hs-CRP and a diagnosis of ADHD by age 10. Maternal inflammation is also associated with ADHD symptom load in the entire cohort.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury

Suzanne M. Green-Fulgham, Michael J. Lacagnina, Kendal F. Willcox, Jiahe Li, Michael E. Harland, Adriano Polican Ciena, Igor R. Correia Rocha, Jayson B. Ball, Renee A. Dreher, Younus A. Zuberi, Joseph M. Dragavon, Marucia Chacur, Steven F. Maier, Linda R. Watkins, Peter M. Grace

Summary: Regular aerobic activity, specifically voluntary wheel running, can reduce the risk of chronic pain by inhibiting MAC and preserving myelin integrity at the site of peripheral nerve injury.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Neuronanomedicine for Alzheimer's and Parkinson's disease: Current progress and a guide to improve clinical translation

India Boyton, Stella M. Valenzuela, Lyndsey E. Collins-Praino, Andrew Care

Summary: Neuronanomedicine is a multidisciplinary field that aims to develop innovative nanotechnologies for the treatment of neurodegenerative disorders. Nanoparticles are an important component of neuronanomedicine, as they can improve drug properties and enhance safety and delivery across the blood-brain barrier. However, a major challenge for neuronanomedicine translation is the poor understanding of bio-nano interactions, partly due to inconsistent reporting in published works. This review provides specific recommendations to guide researchers in harnessing the unique properties of nanoparticles for breakthrough treatments of Alzheimer's and Parkinson's disease.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Mind versus body: Perceived stress and biological stress are independently related to cognitive decline

Celine De Looze, Cathal McCrory, Aisling O'Halloran, Silvia Polidoro, Rose Anne Kenny, Joanne Feeney

Summary: Our study found that subjective measures of stress and biological metrics may be independently associated with cognitive function over time in older adults, hinting at potential different underlying mechanisms.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Choroid plexus volume is increased in mood disorders and associates with circulating inflammatory cytokines

Beatrice Bravi, Elisa Maria Teresa Melloni, Marco Paolini, Mariagrazia Palladini, Federico Calesella, Laura Servidio, Elena Agnoletto, Sara Poletti, Cristina Lorenzi, Cristina Colombo, Francesco Benedetti

Summary: Depressed patients show changes in immune-inflammatory markers in their blood and cerebrospinal fluid. The Choroid Plexus, located at the base of the brain ventricles, plays a key role in regulating the exchange of substances between the brain and immune cells. Patients with bipolar disorder or major depressive disorder have larger Choroid Plexus volumes compared to healthy controls. Age and levels of circulating cytokines are associated with Choroid Plexus volumes in the clinical groups.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis

Mingxuan Zheng, Huaiyu Ye, Xiaoying Yang, Lijun Shen, Xuemei Dang, Xiaoli Liu, Yuying Gong, Qingyuan Wu, Li Wang, Xing Ge, Xiaoli Fang, Benchi Hou, Peng Zhang, Renxian Tang, Kuiyang Zheng, Xu-Feng Huang, Yinghua Yu

Summary: Obesity is linked to cognitive dysfunction and neurodegenerative disease. The connection between the gut microbiota and the brain is altered in obesity. The probiotic Clostridium butyricum can improve cognitive impairment caused by obesity and prevent gut microbiota dysbiosis and inflammation.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Stem-cell derived neurosphere assay highlights the effects of viral infection on human cortical development

Edward Drydale, Phalguni Rath, Katie Holden, Gregory Holt, Laurissa Havins, Thomas Johnson, James Bancroft, Lahiru Handunnetthi

Summary: This study created a novel three-dimensional neurosphere assay using induced pluripotent stem cell differentiation and live cell imaging techniques to investigate the effect of a simulated viral infection on cortical development. The findings demonstrated that the infection led to reduced radial glial growth and neural migration.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

An integral blood-brain barrier in adulthood relies on microglia-derived PDGFB

Yuancheng Weng, Ningting Chen, Rui Zhang, Jian He, Xukai Ding, Guo Cheng, Qianqian Bi, Ying-mei Lu, Xiao Z. Shen, Shu Wan, Peng Shi

Summary: This study reveals that microglia is the primary cellular source of PDGFB in adults, and microglial PDGFB is crucial for maintaining BBB integrity in adult mice.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Gonadal hormones impart male-biased behavioral vulnerabilities to immune activation via microglial mitochondrial function

Evan A. Bordt, Haley A. Moya, Young Chan Jo, Caitlin T. Ravichandran, Izabella M. Bankowski, Alexis M. Ceasrine, Christopher J. Mcdougle, William A. Carlezon Jr, Staci D. Bilbo

Summary: There is a strong male bias in many neurodevelopmental disorders such as autism spectrum disorder, but the mechanisms behind this bias are unknown. Infection during the perinatal period increases the risk of neurodevelopmental disorders. Using a mouse model, researchers found that early-life immune activation only induced deficits in social behaviors in male mice. These behavioral changes were associated with alterations in microglial immune signaling, mitochondrial morphology, gene expression, and function specifically in microglia, the brain's innate immune cells. Furthermore, the vulnerability to early-life immune activation and its effects on behavior and microglial mitochondria were programmed by the male-typical perinatal gonadal hormone surge. These findings highlight the role of microglia-specific mechanisms shaped by early developmental events in regulating male social behavior throughout lifespan.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Interleukin-15 alters hippocampal synaptic transmission and impairs episodic memory formation in mice

Maria Amalia Di Castro, Stefano Garofalo, Alessandro Mormino, Laura Carbonari, Erika Di Pietro, Eleonora De Felice, Myriam Catalano, Laura Maggi, Cristina Limatola

Summary: Cytokines, such as interleukin-15 (IL-15), play important roles in modulating the central nervous system (CNS). In this study, the authors found that exposure to IL-15 enhances GABA release and reduces glutamatergic currents in hippocampal slices. Chronic treatment with IL-15 has negative effects on memory formation. Serotonin is involved in mediating these effects, as a selective 5-HT3A receptor antagonist prevents the effects on inhibitory neurotransmission and improves performance in a memory test.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling

Nikhitha Sreenivas, Michael Maes, Hansashree Padmanabha, Apoorva Dharmendra, Priyanka Chakkera, Saptamita Paul Choudhury, Fazal Abdul, Thrinath Mullapudi, Vykuntaraju K. Gowda, Michael Berk, John Vijay Sagar Kommu, Monojit Debnath

Summary: Neurodevelopmental disorders (NDDs) are a spectrum of conditions with both common and differing characteristics in terms of phenome, symptomatome, neuropathology, risk factors and underlying mechanisms. This study investigates the possibility of a shared immune etiology among three early-onset NDDs, namely Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD) and Intellectual Disability Disorder (IDD).

BRAIN BEHAVIOR AND IMMUNITY (2024)